Trial intelligence / Profile preview

Daily vs. High-dose Weekly Prednisone in DMD

NCT00110669Phase 3Completed

Sponsor
Cooperative International Neuromuscular Research Group
Start
Jan 2004
Primary completion
Dec 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of prednisone in Duchenne muscular dystrophy (DMD), sponsored by Cooperative International Neuromuscular Research Group. Started Jan 2004; status: completed.

02

Drugs

prednisone
03

Conditions

Duchenne muscular dystrophy (DMD)

Beyond the preview

Go deeper on NCT00110669.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00110669.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call